Vireo Growth Inc. (VREOF) stock
Close on Oct 19, 2026Market cap $443.48MP/E –Yield –
Vireo Growth Inc. grew revenue 255.8% to $673.67M over the twelve months to Sep 30, 2026. Free cash flow was -$98.11M. At the latest close the market valued the company at $443.48M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $443.48M
- P/E ratio
- –
- Price to sales
- 0.66
- Price to book
- 0.90
- Dividend yield
- –
- Free cash flow yield
- -22.12%
Fundamentals
- Revenue
- $673.67M
- Net income
- -$64.81M
- EPS, diluted
- -$1.67
- Free cash flow
- -$98.11M
- Book value per share
- $10.05
- Diluted shares
- 49M
Trading
- Next earnings
- Mar 16, 2027 (estimated, before the open)
- Previous close
- $9.00
- Open
- $8.83
- Day's range
- $8.80 – $9.08
- Volume
- 12,697
- Average volume (20 days)
- 42,503
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | VREOF | S&P 500 | Difference | VREOF per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -21.7% | +0.6% | −22.3 pts | ||
| 3 months | -7.9% | +3.4% | −11.2 pts | ||
| Year to date | -51.0% | +13.3% | −64.3 pts | ||
| 1 year | -56.0% | +16.6% | −72.6 pts | ||
| 3 years | +78.8% | +86.4% | −7.6 pts | +21.4% | +23.1% |
| 5 years | -81.2% | +81.9% | −163.1 pts | -28.4% | +12.7% |
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Vireo Growth filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Update
- Update
- Update
About Vireo Growth
Pharmaceutical Preparations
Vireo Growth Inc. is a vertically integrated cannabis company that cultivates, manufactures, wholesales, and retails cannabis products. Its operations span three primary divisions: cultivation, production, and retail dispensaries. The company produces and packages cannabis items across multiple formats, including inhalables such as flower, concentrates, and vaporizers; ingestibles such as edibles, tablets, and tinctures; and topicals. Vireo Growth serves medical patients and adult-use consumers through its retail stores, while also supplying third-party licensed dispensaries through wholesale channels.
Company profile, executives and historyVireo Growth stock: common questions
What is Vireo Growth's stock price?
VREOF closed at $9.01 on Oct 19, 2026, up 0.11% on the day.
What is Vireo Growth's market cap?
Vireo Growth was worth $443.48M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is VREOF's P/E ratio?
Vireo Growth lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.67), so it has no meaningful P/E ratio.
How much revenue does Vireo Growth make?
Vireo Growth reported revenue of $673.67M for the twelve months to Sep 30, 2026, up 255.8% from a year earlier.
Does Vireo Growth pay a dividend?
No. Vireo Growth has not paid a cash dividend over the last twelve months.
When does Vireo Growth report earnings next?
Vireo Growth is expected to report Q4 FY2026 results on Mar 16, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has VREOF stock performed over the past year?
Including dividends, VREOF returned -56.0% over the past year, against +16.6% for the S&P 500.
Who are Vireo Growth's competitors?
Companies most similar to Vireo Growth by business, industry and size include AAWH, OGI, CRLBF, JUSH, TRLV.
See a number that looks wrong?